LinusBio

LinusBio is a pioneering precision medicine platform company developing exposomic biomarkers from single strands of hair to enable earlier disease diagnoses, enhanced patient monitoring, and accelerated drug development. The company's proprietary temporal exposomics sequencing platform uses robotics, laser systems, and mass spectrometry to analyze the molecular growth rings in hair, revealing thousands of biological features across multiple time points. LinusBio's AI-powered pipeline transforms these exposomic readouts into actionable clinical insights. The company's lead product, ClearStrand-ASD, is the first commercially available non-invasive diagnostic aid for Autism Spectrum Disorder, capable of detecting a biomarker associated with autism in children as young as one month of age using a single hair strand.